Gambling disorder and other behavioral addictions: Recognition and treatment

Harvard Review of Psychiatry

Volumn 23, Issue 2, 2015, Pages 134-146

  Yau, Yvonne H C ^a   Potenza, Marc N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Behavioral addiction; Diagnosis; Disordered gambling; Internet gaming disorder; Neurobiology

Indexed keywords

OPIATE ANTAGONIST;

ADDICTION; BEHAVIOR THERAPY; COMORBIDITY; FAMILY HISTORY; GENETIC ANALYSIS; HUMAN; NEUROBIOLOGY; NEUROCHEMISTRY; PATHOLOGICAL GAMBLING; PERSONALITY; PHENOMENOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; TREATMENT RESPONSE; BEHAVIOR, ADDICTIVE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EPIDEMIOLOGY; GAMBLING; INTERNET; PSYCHOLOGY;

BEHAVIOR, ADDICTIVE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GAMBLING; HUMANS; INTERNET;

EID: 84925348633     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000051     Document Type: Review

References (187)

1. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction 2006;101:142-51.
2. Shaffer HJ, LaPlante DA, LaBrie R, Kidman RC, Donato AN, Stanton MV. Toward a syndrome model of addiction: multiple expressions, common etiology. Harv Rev Psychiatry 2004;12: 367-74.
3. Wareham JD, Potenza MN. Pathological gambling and substance use disorders. Am J Drug Alcohol Abuse 2010;36: 242-7.
4. Maddux JF, Desmond DP. Addiction or dependence? Addiction 2000;95:661-5.
5. Frascella J, Potenza MN, Brown LL, Childress AR. Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci 2010;1187:294-315.
6. Karim R, Chaudhri P. Behavioral addictions: an overview. J Psychoactive Drugs 2012;44:5-17.
7. Holden C. Behavioral addictions debut in proposed DSM-V. Science 2010;327:935.
8. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008;75:63-75.
9. Grant JE, Schreiber L, Odlaug BL. Phenomenology and treatment of behavioural addictions. Can J Psychiatry 2013;58: 252-59.
10. Leeman RF, Potenza MN. A targeted review of the neurobiology and genetics of behavioral addictions: an emerging area of research. Can J Psychiatry 2013;58:260-73.
11. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003;160:1041.
12. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: results of two national surveys. Am J Psychiatry 2006;163:297-302.
13. Shaw MC, Forbush KT, Schlinder J, Rosenman E, Black DW. The effect of pathological gambling on families, marriages, and children. CNS Spectr 2007;12:615-22.
14. Weiser EB. The functions of Internet use and their social and psychological consequences. CyberPsychol Behav 2001;4: 723-43.
15. Lejoyeux M, Weinstein A. Compulsive buying. Am J Drug Alcohol Abuse 2010;36:248-53.
16. Messerlian C, Derevensky JL. Youth gambling: a public health perspective. J Gambl Issues 2005;14:97-116.
17. Wang J, Xiao JJ. Buying behavior, social support and credit card indebtedness of college students. Int J Consum Stud 2009;33:2-10.
18. Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. Psychiatr Clin North Am 2000;23:629-42.
19. th ed. Washington, DC: American Psychiatric Publishing, 2013.
20. Potenza MN. Non-substance addictive behaviors in the context of DSM-5. Addict Behav 2014;39:1-2.
21. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987;144:1184-8.
22. Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999;89:1369-76.
23. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005;66:564-74.
24. Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problemand pathological gambling: systematic review and meta- analysis of population surveys. Addiction 2011; 106:490-8.
25. Blinn-Pike L, Worthy SL, Jonkman JN. Disordered gambling among college students: a meta-analytic synthesis. J Gambl Stud 2007;23:175-83.
26. Gentile DA, Choo H, Liau A, et al. Pathological video game use among youths: a two-year longitudinal study. Pediatrics 2011; 127:e319-29.
27. Ko CH, Yen JY, Chen SH, Yang MJ, Lin HC, Yen CF. Proposed diagnostic criteria and the screening and diagnostic tool of Internet addiction in college students. Compr Psychiatry 2009; 50:378-84.
28. Young KS. Internet addiction: symptoms, evaluation and treatment. In: VandeCreek L, Jackson T, eds. Innovations in clinical practice: a source book. Sarasota, FL: Professional Resource, 1999:19-31.
29. Yau YHC, Crowley MJ, Mayes LC, Potenza MN. Are Internet use and video-game-playing addictive behaviors? Biological, clinical and public health implications for youths and adults. Minerva Psichiatr 2012;53:153-70.
30. Kessler RC, Hwang I, LaBrie R, et al. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 2008;38:1351-60.
31. el-Guebaly N, Mudry T, Zohar J, Tavares H, Potenza MN. Compulsive features in behavioural addictions: the case of pathological gambling. Addiction 2012;107:1726-34.
32. Bland RC, Newman SC, Orn H, Stebelsky G. Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 1993; 38:108-12.
33. th ed. Philadelphia: Wolters Kluwer, 2014.
34. Yen J-Y, Ko C-H, Yen C-F, Chen C-S, Chen C-C. The association between harmful alcohol use and Internet addiction among college students: comparison of personality. Psychiatr Clin Neurosci 2009;63:218-24.
35. Mazhari S. Association between problematic Internet use and impulse control disorders among Iranian university students. Cyberpsychol Behav Soc Netw 2012;15:270-3.
36. Dowling NA, Brown M. Commonalities in the psychological factors associated with problem gambling and Internet dependence. Cyberpsychol Behav Soc 2010;13:437-41.
37. Blaszczynski A, Nower L. A pathways model of problem and pathological gambling. Addiction 2002;97:487-99.
38. Chou KL, Afifi TO. Disordered (pathologic or problem) gambling and axis I psychiatric disorders: results fromthe National Epidemiologic Survey on Alcohol and Related Conditions. Am J Epidemiol 2011;173:1289-97.
39. Pilver CE, Libby DJ, Hoff RA, Potenza MN. Gender differences in the relationship between gambling problems and the incidence of substance-use disorders in a nationally representative population sample. Drug Alcohol Depend 2013;133:204-11.
40. Pilver CE, Potenza MN. Increased incidence of cardiovascular conditions among older adults with pathological gambling features in a prospective study. J Addict Med 2013;7:387-93.
41. Bullock SA, Potenza MN. Pathological gambling: neuropsychopharmacology and treatment. Curr Psychopharmacol 2012; 1:67-85.
42. Chambers RA, Bickel WK, Potenza MN. A scale-free systems theory of motivation and addiction. Neurosci Biobehav Rev 2007;31:1017-45.
43. Redish AD, Jensen S, Johnson A. A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci 2008;31:415-37.
44. Goldstein RZ, Alia-Klein N, Tomasi D, et al. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry 2007;164:43-51.
45. Fineberg NA, Chamberlain SR, Goudriaan AE, et al. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectr 2014;19:69-89.
46. Verdejo-Garcia A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008;32:777-810.
47. Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology 2012;219: 469-90.
48. Tavares H, Zilberman ML, Hodgins DC, El-Guebaly N. Comparison of craving between pathological gamblers and alcoholics. Alcohol Clin Exp Res 2005;29:1427-31.
49. Potenza MN, Koran LM, Pallanti S. The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions. Psychiatr Res 2009;170:22-31.
50. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 1995;56 suppl 4:3-6; discussion 53-5.
51. Fineberg NA, Potenza MN, Chamberlain SR, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010;35:591-604.
52. Odlaug BL, Chamberlain SR, Grant JE. Motor inhibition and cognitive flexibility in pathologic skin picking. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:208-11.
53. Sumnall HR, Wagstaff GF, Cole JC. Self-reported psychopathology in polydrug users. J Psychopharmacol 2004;18:75-82.
54. Odlaug BL, Chamberlain SR, Kim SW, Schreiber LRN, Grant JE. A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity. Psychol Med 2011;41:2111-9.
55. Goudriaan AE, Oosterlaan J, De Beurs E, Van den Brink W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decisionmaking in the prediction of relapse in pathological gamblers. Psychol Med 2008;38:41-50.
56. Lawrence A, Luty J, Bogdan N, Sahakian B, Clark L. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction 2009;104:1006-15.
57. Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res Cogn Brain Res 2005;23:137-51.
58. Ko CH, Hsiao S, Liu GC, Yen JY, Yang MJ, Yen CF. The characteristics of decision making, potential to take risks, and personality of college students with Internet addiction. Psychiatry Res 2010;175:121-5.
59. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 2005;8:1481-9.
60. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol 2006;17:651-67.
61. Mitchell MR, Potenza MN. Addictions and personality traits: impulsivity and related constructs. Curr Behav Neurosci Rep 2014;1:1-12.
62. Petry NM. Discounting of probabilistic rewards is associated with gambling abstinence in treatment-seeking pathological gamblers. J Abnorm Psychol 2012;121:151-9.
63. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217-38.
64. Weinstein AM. Computer and video game addiction - a comparison between game users and non-game users. Am J Drug Alcohol Abuse 2010;36:268-76.
65. Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 1992;49:538-44.
66. Volkow ND, Wang GJ, Fowler JS, et al. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 1994;16:255-62.
67. Linnet J, Moller A, Peterson E, Gjedde A, Doudet D. Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scand J Psychol 2011;52:28-34.
68. Joutsa J, Johansson J, Niemelä S, et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 2012;60:1992-9.
69. Linnet J, Møller A, Peterson E, Gjedde A, Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 2011;106:383-90.
70. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001;158:2015-21.
71. Kim SH, Baik S-H, Park CS, Kim SJ, Choi SW, Kim SE. Reduced striatal dopamine D2 receptors in people with Internet addiction. Neuroreport 2011;22:407-11.
72. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med 2009;3:8-18.
73. Huang XF, Zavitsanou K, Huang X, et al. Dopamine transporter and D2 receptor binding densities inmice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res 2006;175:415-9.
74. Geiger BM, Behr GG, Frank LE, et al. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 2008;22:2740-6.
75. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010;13:635-41.
76. Johnson JA, Lee A, Vinson D, Seale JP. Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol Clin Exp Res 2013;37 suppl 1:E253-9.
77. Clark L, Stokes PR, Wu K, et al. Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 2012;63:40-6.
78. Boileau I, Payer D, Chugani B, et al. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction 2013;108:953-63.
79. Potenza MN. How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci 2013;7:206.
80. Boileau I, Payer D, Chugani B, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)- PHNO. Mol Psychiatry 2014;19:1305-13.
81. Potenza MN. The neural bases of cognitive processes in gambling disorder. Trends Cogn Sci 2014;18:429-38.
82. Cocker PJ, Le Foll B, Rogers RD, Winstanley CA. A selective role for dopamine D4 receptors in modulating reward expectancy in a rodent slot machine task. Biol Psychiatry 2014;75:817-24.
83. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-95.
84. Voon V, Sohr M, Lang AE, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011;69:986-96.
85. Leeman RF, Billingsley BE, Potenza MN. Impulse control disorders in Parkinson's disease: background and update on prevention and management. Neurodegener Dis Manag 2012;2: 389-400.
86. McElroy SL, Nelson E, Welge J, Kaehler L, Keck P. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 2008;69:433-40.
87. Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 2008;89:298-303.
88. Zack M, Poulos CX. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 2007;32:1678-86.
89. Zack M, Poulos CX. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 2004;29:195-207.
90. Nordin C, Eklundh T. Altered CSF 5-HIAA disposition in pathological male gamblers. CNS Spectr 1999;4:25-33.
91. de Castro IP, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J. Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO-A and the 5-HT transporter genes. Mol Psychiatry 2002;7:927-8.
92. Ibanez A, Perez de Castro I, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 2000; 5:105-9.
93. Potenza MN, Walderhaug E, Henry S, et al. Serotonin 1B receptor imaging in pathological gambling. World J Biol Psychiatry 2013;14:139-45.
94. Meyer G, Schwertfeger J, Exton MS, et al. Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 2004;29:1272-80.
95. Pallanti S, Bernardi S, Allen A, et al. Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine. J Psychopharmacol 2010;24:847-53.
96. Elman I, Becerra L, Tschibelu E, Yamamoto R, George E, Borsook D. Yohimbine-induced amygdala activation in pathological gamblers: a pilot study. PLoS One 2012;7:e31118.
97. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001;49:914-21.
98. Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 2010;197:330-1.
99. Balodis IM, Kober H, Worhunsky PD, Stevens MC, Pearlson GD, Potenza MN. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry 2012;71:749-57.
100. Choi J-S, Shin Y-C, Jung WH, et al. Altered brain activity during reward anticipation in pathological gambling and obsessive-compulsive disorder. PLoS One 2012;7:e45938.
101. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005;8:147-8.
102. Tanabe J, Thompson L, Claus E, Dalwani M, Hutchison K, Banich MT. Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum Brain Mapp 2007;28:1276-86.
103. Power Y, Goodyear B, Crockford D. Neural correlates of pathological gamblers preference for immediate rewards during the iowa gambling task: an fMRI study. J Gambl Stud 2011;1-14.
104. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry 2003;60:828-36.
105. Goudriaan AE, De Ruiter MB, Van Den Brink W, Oosterlaan J, Veltman DJ. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addiction Biol 2010;15:491-503.
106. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005;58:787-95.
107. van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE. Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol Psychiatry 2012;71:741-8.
108. Leyton M, Vezina P. On cue: striatal ups and downs in addictions. Biol Psychiatry 2012;72:e21-2.
109. Ko C-H, Liu G-C, Hsiao S, et al. Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 2009;43:739-47.
110. Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD. Neural correlates of food addiction. Arch Gen Psychiatry 2011;68:808-16.
111. Wrase J, Schlagenhauf F, Kienast T, et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 2007;35:787-94.
112. Hommer DW, Bjork JM, Gilman JM. Imaging brain response to reward in addictive disorders. Ann N Y Acad Sci 2011;1216:50-61.
113. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 2008;363:3181-9.
114. de Greck M, Enzi B, Prösch U, Gantman A, Tempelmann C, Northoff G. Decreased neuronal activity in reward circuitry of pathological gamblers during processing of personal relevant stimuli. Hum Brain Mapp 2010;31:1802-12.
115. Raab G, Elger C, Neuner M, Weber B. A neurological study of compulsive buying behaviour. J Consum Policy 2011;34:401-13.
116. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science 2012;335:601-4.
117. van Holst RJ, de Ruiter MB, van den Brink W, Veltman DJ, Goudriaan AE. A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug Alcohol Depend 2012;124:142-8.
118. Joutsa J, Saunavaara J, Parkkola R, Niemelä S, Kaasinen V. Extensive abnormality of brain white matter integrity in pathological gambling. Psychiatry Res 2011;194:340-6.
119. Rahman AS, Xu J, Potenza MN. Hippocampal and amygdalar volumetric differences in pathological gambling: a preliminary study of the associations with the behavioral inhibition system. Neuropsychopharmacology 2014;39:738-45.
120. Yip SW, Lacadie CM, Xu J, et al. Reduced genual corpus callosal white matter integrity in pathological gambling and its relationship to alcohol abuse or dependence. World J Biol Psychiatry 2013;14:129-38.
121. Lin F, Zhou Y, Du Y, et al. Abnormal white matter integrity in adolescents with Internet addiction disorder: a tract-based spatial statistics study. PLoS One 2012;7:e30253.
122. Yuan K, Qin W, Wang G, et al. Microstructure abnormalities in adolescents with Internet addiction disorder. PLoS One 2011;6:e20708.
123. Miner MH, Raymond N, Mueller BA, Lloyd M, Lim KO. Preliminary investigation of the impulsive and neuroanatomical characteristics of compulsive sexual behavior. Psychiatry Res 2009;174:146-51.
124. Slutske WS, Zhu G, Meier MH, Martin NG. Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry 2010;67:624-30.
125. Blanco C, Myers J, Kendler KS. Gambling, disordered gambling and their association with major depression and substance use: a Web-based cohort and twin-sibling study. Psychol Med 2012;42:497-508.
126. Lobo DS, Kennedy JL. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009;104:1454-65.
127. Shah KR, Eisen SA, Xian H, Potenza MN. Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin Registry. J Gambl Stud 2005;21:179-203.
128. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 2005;8:1450-7.
129. Slutske WS, Ellingson JM, Richmond-Rakerd LS, Zhu G, Martin NG. Shared genetic vulnerability for disordered gambling and alcohol use disorder in men and women: evidence from a national community-based Australian twin study. Twin Res Hum Genet 2013;16:525-34.
130. Black DW, Monahan PO, Temkit MH, Shaw M. A family study of pathological gambling. Psychiatry Res 2006;141:295-303.
131. Schneider JP, Schneider BH. Couple recovery from sexual addiction: research findings of a survey of 88 marriages. Sex Addict Compulsivity 1996;3:111-26.
132. McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994;55:242-8.
133. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996;6:223-34.
134. Lobo DSS, Souza RP, Tong RP, et al. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol 2010;85:33-7.
135. Han DH, Lee YS, Yang KC, Kim EY, Lyoo IK, Renshaw PF. Dopamine genes and reward dependence in adolescents with excessive Internet video game play. J Addict Med 2007;1:133-8.
136. de Castro IP, Ibánez A, Saiz-Ruiz J, Fernández-Piqueras J. Genetic contribution to pathological gambling: possible association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected men. Pharmacogenet Genomics 1999;9:397-400.
137. Lee YS, Han D, Yang KC, et al. Depression like characteristics of 5HTTLPR polymorphism and temperament in excessive internet users. J Affect Disord 2008;109:165-9.
138. Lind PA, Zhu G, Montgomery GW, et al. Genome-wide association study of a quantitative disordered gambling trait. Addict Biol 2012;18:511-22.
139. Yip S, Potenza MN. Treatment of gambling disorders. Curr Treat Options Psychiatry 2014;1:189-203.
140. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA. Naltrexone in the treatment of alcohol dependence. New Engl J Med 2001;345:1734-9.
141. O'Brien C, Thomas McLellan A. Myths about the treatment of addiction. Lancet 1996;347:237-40.
142. Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008;69:783-9.
143. Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol 2007;27:620-4.
144. Grant J, Kim SW. A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry 2001;13:229-31.
145. Raymond NC, Grant JE, Kim SW, Coleman E. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol 2002;17:201-5.
146. Grant JE. Three cases of compulsive buying treated with naltrexone. Int J Psychiatry Clin Pract 2003;7:223-5.
147. Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006;163:303-12.
148. Grant JE, Kim SW, Hollander E, Potenza MN. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology 2008;200:521-7.
149. Oslin DW, Berrettini W, Kranzler HR, et al. A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003;28:1546-52.
150. Avena NM, Bocarsly ME, Rada P, Kim A, Hoebel BG. After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol Behav 2008;94:309-15.
151. Colantuoni C, Rada P, McCarthy J, et al. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes Res 2002;10:478-88.
152. Avena NM, Rada P, Hoebel BG. Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr 2009; 139:623-8.
153. Bocarsly ME, Berner LA, Hoebel BG, Avena NM. Rats that binge eat fat-rich food do not show somatic signs or anxiety associated with opiate-like withdrawal: implications for nutrient-specific food addiction behaviors. Physiol Behav 2011;104: 865-72.
154. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000; 47:813-7.
155. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002;63:501-7.
156. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002;14:9-15.
157. Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 2003;18:243-9.
158. Wainberg ML, Muench F, Morgenstern J, et al. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. J Clin Psychiatry 2006;67:1968-73.
159. Dell''Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive Internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. J Clin Psychiatry 2008;69:452-6.
160. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate- modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007;62:652-7.
161. Grant JE, Odlaug BL, Chamberlain SR, et al. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry 2014;75:39-45.
162. Berlin HA, Braun A, Simeon D, et al. A double-blind, placebo-controlled trial of topiramate for pathological gambling. World J Biol Psychiatry 2013;14:121-8.
163. Pallesen S, Mitsem M, Kvale G, Johnsen BH, Molde H. Outcome of psychological treatments of pathological gambling: a review and meta-analysis. Addiction 2005;100:1412-22.
164. Tolin DF. Is cognitive-behavioral therapy more effective than other therapies?: a meta-analytic review. Clin Psychol Rev 2010; 30:710-20.
165. Petry NM, Ammerman Y, Bohl J, et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 2006; 74:555-67.
166. Petry NM. Pathological gambling: etiology, comorbidity, and treatment. Washington, DC: American Psychological Association, 2005.
167. Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev 2012;11:CD008937.
168. Young KS. Cognitive behavior therapy with Internet addicts: treatment outcomes and implications. Cyberpsychol Behav 2007;10:671-9.
169. Raylu N, Oei TP, Loo J. The current status and future direction of self-help treatments for problem gamblers. Clin Psychol Rev 2008;28:1372-85.
170. Carlbring P, Degerman N, Jonsson J, Andersson G. Internet-based treatment of pathological gambling with a three-year follow-up. Cogn Behav Ther 2012;41:321-34.
171. Gamblers Anonymous: Recovery Program. 2013. http://www.gamblersanonymous.org/ga/content/recovery-program
172. Petry NM. Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment. Addict Behav 2003;28:1049-62.
173. Petry NM. Gamblers anonymous and cognitive-behavioral therapies for pathological gamblers. J Gambl Stud 2005;21:27-33.
174. Brewer JA, Grant JE, Potenza MN. The treatment of pathologic gambling. Addict Disord Their Treat 2008;7:1-13.
175. Grant JE, Odlaug BL. Psychosocial interventions for gambling disorders. In: National Center for Responsible Gaming. What clinicians need to know about gambling disorders (Washington, DC: NCRG, 2012:38-52 [vol. 7 in Increasing the odds: a series dedicated to understanding gambling disorders]. At http://www.ncrg.org/resources/monographs
176. Hodgins DC, Currie S, el-Guebaly N, Peden N. Brief motivational treatment for problem gambling: a 24-month follow-up. Psychol Addict Behav 2004;18:293.
177. Copello AG, Velleman RD, Templeton LJ. Family interventions in the treatment of alcohol and drug problems. Drug Alcohol Rev 2005;24:369-85.
178. Potenza MN, Balodis IM, Franco CA, et al. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addictive Behav 2013;27:380-92.
179. LaPlante DA, Nelson SE, LaBrie R, Shaffer HJ. Stability and progression of disordered gambling: lessons from longitudinal studies. Can J Psychiatry 2008;53:52-60.
180. Slutske WS, Blaszczynski A, Martin NG. Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: results from an Australian community-based twin survey. Twin Res Hum Genet 2009;12:425-32.
181. Cunningham JA. Little use of treatment among problem gamblers. Psychiatr Serv 2005;56:1024-5.
182. Gainsbury S, Hing N, Suhonen N. Professional help-seeking for gambling problems: awareness, barriers and motivators for treatment. J Gambl Stud 2013;1-17.
183. Slutske WS, Jackson KM, Sher KJ. The natural history of problem gambling from age 18 to 29. J Abnorm Psychology 2003; 112:263.
184. Volberg RA, Gupta R, Griffiths MD, Olason DT, Delfabbro P. An international perspective on youth gambling prevalence studies. Int J Adolesc Med Health 2010;22:3-38.
185. Welte JW, Barnes GM, Tidwell M-CO, Hoffman JH. The association of form of gambling with problem gambling among American youth. Psychol Addict Behav 2009;23:105.
186. LaPlante DA, Nelson SE, LaBrie RA, Shaffer HJ. Disordered gambling, type of gambling and gambling involvement in the British Gambling Prevalence Survey 2007. Eur J Public Health 2011;21:532-7.
187. Grinols EL. Gambling in America. Cambridge: Cambridge University Press, 2009.